Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux

Blood

Volumn 91, Issue 11, 1998, Pages 4106-4117

  Kim, MiJung ^b   Cooper, Donna D ^b   Hayes, Stanley F ^b   Spangrude, Gerald J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; RHODAMINE 123;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SUBPOPULATION; ENZYME SUBSTRATE; HEMATOPOIETIC CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; STEM CELL;

EID: 0032100452     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4106     Document Type: Article

References (43)

1. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
2. Bertoncello I, Hodgson GS, Bradley TR: Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol 13:999, 1985
3. Spangrude GJ, Johnson GR: Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA 87:7433, 1990
4. Li CL, Johnson GR: Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization. Blood 85:1472, 1995
5. Okada S, Nagayoshi K, Nakauchi H, Nishikawa SI, Miura Y, Suda T: Sequential analysis of hematopoietic reconstitution achieved by transplantation of hematopoietic stem cells. Blood 81:1720, 1993
6. Johnson LV, Walsh ML, Chen LB: Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 77:990, 1980
7. Ploemacher RE, Brons NHC: Cells with marrow and spleen repopulating ability and forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine 123 retention. J Cell Physiol 136:531, 1988
8. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991
9. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus Maandag EC, te Riele HPJ, Berns AJM, Borst P: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491, 1994
10. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM, van Roon MA: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451, 1993
11. Tang Wai DF, Kajiji S, DiCapua F, de Graaf D, Roninson IB, Gros P: Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34:32, 1995
12. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650, 1992
13. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ: Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer 72:543, 1995
14. Zaman GJ, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822, 1994
15. Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC: Fluorescent verapamil derivative for monitoring activity of the multidrug transporter. Mol Pharmacol 40:490, 1991
16. Maftah A, Petit JM, Ratinaud MH, Julien R: 10-N-nonyl-acridine orange: A fluorescent probe which stains mitochondria independently of their energetic state. Biochem Biophys Res Commun 164:185, 1989
17. Kessel D, Beck WT, Kukuruga D, Schulz V: Characterization of multidrug resistance by fluorescent dyes. Cancer Res 51:4665, 1991
18. Reers M, Smith TW, Chen LB: J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30:4480, 1991
19. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB: Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88:3671, 1991
20. Parekh H, Simpkins H: Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system. Biochem Pharmacol 51:301, 1996
21. Spangrude GJ, Brooks DM, Tumas DB: Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 85:1006, 1995
22. Nibley WE, Spangrude GJ: Primitive stem cells alone mediate rapid marrow recovery and mulitlineage engraftment after transplantation. Bone Marrow Transplant 21:345, 1998
23. Shen F-W: Monoclonal antibodies to mouse lymphocyte differentiation alloantigens, in Hämmerling GJ, Hämmerling U, Kearney JF (eds): Monoclonal Antibodies and T-Cell Hybridomas. Amsterdam, The Netherlands, Elsevier/North Holland Biomedical, 1981, p 25
24. Spangrude GJ, Scollay R: Differentiation of hematopoietic stem cells in irradiated mouse thyrnic lobes. Kinetics and phenotype of progeny. J Immunol 145:3661, 1990
25. Spangrude GJ: The pre-spleen-colony-forming unit assay: Measurement of spleen colony-forming unit regeneration. Curr Top Microbiol Immunol 177:31, 1992
26. Phillips RL, Reinhart AJ, Van Zant G: Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics. Proc Natl Acad Sci USA 89:11607, 1992
27. Witkowski JM, Gorgas G, Miller RA: Reciprocal expression of P-glycoprotein and TAP1 accompanied by higher expression of MHC class I antigens in T cells of old mice. J Gerontol 51:B76, 1996
28. Pilarski LM, Paine D, McElhaney JE, Cass CE, Belch AR: Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging. Am J Hematol 49:323, 1995
29. Zhou DC, Ramond S, Viguie F, Faussat AM, Zittoun R, Marie JP: Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines. Int J Cancer 65:365, 1996
30. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902, 1994
31. Chen LB, Summerhayes IC, Johnson LV, Walsh ML, Bernal SD, Lampidis TJ: Probing mitochondria in living cells with rhodamine 123. Cold Spring Harb Symp Quant Biol 46:141, 1982
32. Koponen M, Grieder A, Hauser R, Loor F: Interference of cyclosporin with lymphocyte proliferation: Effects on mitochondria and lysosomes of cyclosporin-sensitive or -resistant cell clones. Cell Immunol 93:486, 1985
33. Visser JWM, de Vries P, Hogeweg-Platenburg MGC, Bayer J, Schoeters G, Van Den Heuvel R, Mulder DH: Culture of hematopoietic stem cells purified from murine bone marrow. Semin Hematol 28:117, 1991
34. Yamamoto Y, Yasumizu R, Amou Y, Watanabe N, Nishio N, Toki J. Fukuhara S, Ikehara S: Characterization of peripheral blood stem cells in mice. Blood 88:445, 1996
35. Zijlmans JMJM, Visser JW, Kleiverda K, Kluin PM, Willemze R, Fibbe WE: Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci USA 92:8901, 1995
36. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797, 1996
37. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL: Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122:897, 1993
38. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P: Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028, 1997
39. Leemhuis T, Yoder MC, Grigsby S, Aguero B, Eder P, Srour EF: Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. Exp Hematol 24:1215, 1996
40. Uchida N, Combs J, Chen S, Zanjani E, Hoffman R, Tsukamoto A: Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 88:1297, 1996
41. Raghu G, Park SW, Roninson IB, Mechetner EB: Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol 24:1258, 1996
42. Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I, Andreeff M, Huber H: Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88:1747, 1996
43. Hanania EG, Deisseroth AB: Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther 1:21, 1994